Fox Chase Cancer Center News

PHILADELPHIA (May 19, 2021)—In a study released today, researchers at Fox Chase Cancer Center and a team of international researchers identified a mutated gene called LRRK2 that may indicate a predisposition to malignant mesothelioma.  

PHILADELPHIA (May 18, 2021)—Data from a new study by researchers at Fox Chase Cancer show that avapritinib, a platelet-derived growth factor receptor A (PDGFRA) inhibitor, has a “clinically meaningful benefit” for the treatment of gastrointestinal stromal tumors (GIST) with PDGFRA D842V mutations.

PHILADELPHIA (May 18, 2021) – In a study posted today, researchers at Fox Chase Cancer Center announced that they have discovered a new factor contributing to early lung cancer formation.

PHILADELPHIA (May 14, 2021)—In early 2020, Sanjay S. Reddy, MD, FACS, surgical oncologist and co-director of the Marvin & Concetta Greenberg Pancreatic Cancer Institute at Fox Chase Cancer Center, co-authored an article examining the paradox that healthcare providers were facing. Should they continue to treat cancer patients as they normally would, which might increase the risk of contracting COVID-19? Or should they try alternative strategies to treatment, which could lead to worse cancer-related outcomes?

PHILADELPHIA (May 14, 2021)—In a recent study, researchers at Fox Chase Cancer Center found that there are major limitations in using cystoscopy for predicting the presence of muscle-invasive bladder cancer in patients who are candidates for bladder removal.

PHILADELPHIA (May 12, 2021)—In a recent study, researchers at Fox Chase Cancer Center showed that the combined use of the drugs venetoclax (Venclexta) and ibrutinib (Imbruvica) could help eradicate residual disease in patients with chronic lymphocytic leukemia (CLL).

PHILADELPHIA (May 11, 2021)—Cancer health disparities is a broad and complex issue that requires new approaches and adjustments to the existing cancer continuum framework.  Evelyn González, MA, senior director of Fox Chase Cancer Center’s Office of Community Outreach and Engagement, joined a team of experts from across the United States to co-lead a process to develop a framework aimed at addressing cancer care disparities.   

PHILADELPHIA (May 11, 2021)—Jose Russo, MD, FACP, senior member and director of The Irma H. Russo, MD, Breast Cancer Research Laboratory at Fox Chase Cancer Center, recently published a study showing how significant differences in gene-to-gene interaction provide long-term breast cancer protection in women who have been pregnant versus those who have not.